Akston Biosciences
Sylaja Murikipudi, Ph.D. is responsible for ensuring that Akston’s products meet internal as well as regulatory and safety requirements. She guides the Quality Control team as they develop necessary assays and conduct testing. Sylaja worked at SmartCells, Inc. and when the same management team asked her to join Akston, she jumped at the opportunity.
Sylaja received her P.h.D from the Division of Health Sciences and Technology at Massachusetts Institute of Technology.
This person is not in any offices
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.